Search results
Found 15 matches for
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
8 May 2024
The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.
Pancreatic cancer could be diagnosed up to three years earlier
3 November 2022
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates.
Cancer at Oxford
29 September 2022
Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series
Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
28 June 2022
Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
Predicting early recurrence of pancreatic cancer
3 May 2022
Dr Daniel Hughes and colleagues identify NUDT15 as a potential biomarker for pancreatic cancer recurrence following surgery.
Groundbreaking University of Oxford research could lead to early diagnosis of pancreatic cancer
27 January 2022
New research into the onset of diabetes which could go on to help in the early diagnosis of pancreatic cancer is being led by scientists at the University of Oxford.
Identifying protein biomarkers for pancreatic cancer
26 January 2022
Dr Christiana Kartsonaki and colleagues from the China Kadoorie Biobank have identified several proteins in the blood that are associated with an increased risk of pancreatic cancer.
Oxford cancer symptoms paper is the second most read paper in the British Journal of General Practice in 2021
21 January 2022
The team identified new symptoms that could help doctors diagnose pancreatic cancer.
New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Dr Weiqi Liao and Professor Julia Hippisley-Cox have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms.
Pancreatic cancer early detection funds awarded to OxCODE researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
OxCODE funds three early detection projects
27 August 2021
Congratulations to Alistair Easton, Siim Pauklin, Susie Shapiro and their collaborators who have been awarded funding in the second round of the OxCODE Funding Scheme.
Oxford success at the early detection sandpit on pancreatic cancer
21 April 2021
Professor Eric O’Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
New funding for early diagnosis research using platelets
29 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Potential of DNA-based blood tests for detecting pancreatic cancer earlier
11 December 2020
Dr Shivan Sivakumar and colleagues evaluate the current progress and future potential in using genetic and epigenetic methods for detecting pancreatic cancer DNA in the blood.
Searching for a pancreatic cancer DNA signature
26 November 2019
Dr Siim Pauklin wins funding from Pancreatic Cancer UK to accelerate the detection of this devastating disease.